FREQUENCY OF DEPRESSION AND ANXIETY IN PATIENTS ATTENDING A DIABETES CLINIC

Authors

  • Nadia Azad
  • Murtaza Gondal
  • Nadeem Abbas
  • Afshan Shahid

Abstract

Background: Depression is very common among people with type-2 diabetes and is associated with poor treatment compliance and outcome. This study was done to see the frequency of depression in patients with established type-2 diabetes attending a diabetes clinic in a tertiary care hospital. Methods: One hundred and ten patients with chronic type-2 diabetes were included in this cross sectional study, excluding type-1 diabetics, patients with severe co-morbid illness with type-2 diabetes and patients with some psychiatric illness. Hospital Anxiety and Depression Scale was used to assess depression and anxiety in these patients. Results: Almost 50% of patients were found to have anxiety and depression in our study. Female gender, lack of education and housewives were found to be effected more while duration of diabetes, treatment and control of diabetes have little effect on anxiety and depression in patients with chronic type-2 diabetes patients. Conclusion: There is a high incidence of depression and anxiety in patients with chronic type-2 diabetes and clinicians must screen regularly for better care of these patients.Keywords: Depression, anxiety, type-2 diabetes mellitus, diabetes clinic

References

Raval A, Dhanaraj E, Bhansali A, Grover S, Tiwari P. Prevalence & determinants of depression in type-2 diabetes patients in a tertiary care center. Indian J Med Res 2010;132:195–200.

Shera AS, Jawad F, Maqsood A. Prevalence of diabetes in Pakistan. Diabetes Res Clin Pract 2007;76:219–22.

DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000;160:2101–7.

Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 2000;23:934–42.

Katon WJ, Simon G, Russo J, Von-Korff M, Lin EH, Ludman E, et al. Quality of depression care in a population-based sample of patients with diabetes and major depression. Med Care 2004;42:1222–9.

Lin EH, Katon W, Von Korff M, Rutter C, Simon GE, Oliver M, et al. Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes Care 2004;27:2154–60.

de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: a meta-analysis. Psychosomatic Med 2001:63:619–30.

Mahmood K, Aamir AH. Glycemic control status in patients with type-2 diabetes. J Coll Physicians Surg Pak 2005;15:323–5.

Black SA, Markides KS, Ray LA. Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type-2 diabetes. Diabetes Care 2003;26:2822–8.

Shah BM, Gupchup GV, Borrego ME, Raisch DW, Knapp KK. Depressive symptoms in patients with type-2 diabetes in the ambulatory care setting: opportunities to improve outcomes in the course of routine care. J Am Pharm Assoc 2008;48:737–43.

Gonzalez JS, Safren SA, Delahanty LM, Cagliero E, Wexler DJ, Meigs JB, et al. Symptoms of Depression Prospectively Predict Poorer Self-Care in Patients with Type-2 Diabetes. Diabet Med 2008;25:1102–7.

Knol MJ, Twisk JW, Beekman AT, Heine RJ, Snoek FJ, Pouwer F. Depression as a risk factor for the onset of type-2 diabetes mellitus: A meta-analysis. Diabetologia 2006;49:837–45.

Nouwen A, Winkley K, Twisk J, Lloyd CE, Peyrot M, Ismail K, et al. Type-2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis. Diabetologia 2010;53:2480–6

Ali S, Stone MA, Peters JL, Davies MJ, Khunti K. The prevalence of co-morbid depression in adults with type-2 diabetes: a systematic review and meta-analysis. Diabet Med 2006;23:1165–73.

Engum A, Mykletun A, Midthjell K, Holen A, Dohl AA. Depression and diabetes: a large population-based study of sociodemographic, lifestyle, and clinical factors associated with depression in type-1 and type-2 diabetes. Diabetes Care 2005;28:1904–9.

Zuberi SI, Syed EU, Bhatti JA. Association of depression with treatment out comes in type-2 diabetes mellitus: a cross-sectional study from Karachi, Pakistan. BMC Psychiatry 2011;11:27.

Reupa Z, Konlouri A, Sotirapoulou P, Makrinika E, Marneras L, Lahana I, et al. Anxiety and depression in patients with type-2 diabetes mellitus, depending on sex and body mass index. Health Sci J 2009;3(1):32–40.

Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of co-morbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001;24:1069–78.

Khuwaja AK, Lalani S, Dhanani R, Azam IS, Rafique G, White F. Anxiety and depression among out patients with type-2 diabetes: A multicenter study of prevalence and associated factors. Diabetol Metab Syndr 2010;2:72–5.

Khamseh ME, Baradaran HR, Rajabali H. Depression and diabetes in Iranian patients; a comparative study. Int J Psychiatry Med 2007;37:81–6.

Li C, Ford ES, Strine TW, Mokdad AH. Prevalence of depression among U.S adults with depression. Findings from the 2006 behavioral factor surveillance system. Diabetes care 2008;31:105–7.

Kendrick T, Dowrick C, Mcbride A, Howe A, Clarke P, Maisey S, et al. Management of depression in in UK general practice, in relation to scores on depression severity questionnaires: analysis of medical record data. BMJ 2009;42:338:b750.

Papelbaumab M, Lemosa HM, Duchesneab M, Kupfera R, Moreiraa RO, Coutinhoa WF. The association between quality of life, depressive symptoms and glycemic control in a group of type-2 diabetes patients. Diabetes Res Clin Pract 2010;89:227–30

Vileikyte L, Leventhal H, Gonzalez JS, Peyrot M, Rubin RR, Ulbrecht JS, et al. Diabetic Peripheral Neuropathy and Depressive Symptoms. Diabetes Care 2005;28:2378–83.

Ciechanowski PS, Katon WJ, Russo JE. Impact of depressive symptoms on adherence, function and costs. Arch Intern Med 2000;160:3278–85.

Ciechanowski PS, Katon WJ, Russo JE, Hirsch IB. The relationship of depressive symptoms to symptom reporting, self-care and glucose control in diabetes. Gen Hosp Psychiatry 2003;25:246–52.

Gonzalez JS, Safren SA, Cagliero E, Wexler DJ, Delahanty L, Wittenberg E, et al. Depression, self-care and medication adherence in Type-2 Diabetes: relationships across the full range of symptom severity. Diabetes Care 2007;30:2222–7.

Kalsekar ID, Madhaven SS, Amonkar MM, Makela EH, Scott VG, Douglas SM, et al. Depression in patients with type-2 diabetes: Impact on adherence to oral hypoglycemic agents. Ann Pharmacother 2006;40:605–11.

Lustman PJ, Harper GW. Nonpsychiatric physicians’ identification and treatment of depression in patients with diabetes. Compr Psychiatry 1987;28(1):22–7.

Koenig HG, George LK, Peterson BL, Pieper CF. Depression in medically ill hospitalized older adults: prevalence characteristics and course of symptoms according to six diagnostic schemes. Am J Psychiatry 2007; 154:1376–83.

Jacobson AM, de Groot M, Samson JA. The effects of psychiatric disorders and symptoms on quality of life in patients with type-1 and type-2 diabetes mellitus. Qual Life Res 2007;6:11–20.

Miranda J, Munoz R. Intervention for minor depression in primary care patients. Psychosom Med 2003;56:136–41.

Maynors-Wallis LM, Gath DH, Lloyd-Thomas AR, Tomlinson D. Randomized controlled trial comparing problem solving treatment with amitriptyline and placebo for major depression in primary care. Br Med J 2005;310:441–6

Published

2014-09-01